All Pharma News
price-trendAsk Us
Seismic: S-1117 Autoimmune Preclinical Data At AAN 2024

Seismic: S-1117 Autoimmune Preclinical Data At AAN 2024
BUSINESSWIRE
12 Apr 2024
Share Share
Seismic to Present Preclinical Data for Novel Immunoglobulin Sculpting Enzyme

Seismic to Present Preclinical Data for Novel Immunoglobulin Sculpting Enzyme
BUSINESSWIRE
08 Mar 2024
Share Share
Seismic Therapeutic Closes $121 Million Series B Financing

Seismic Therapeutic Closes $121 Million Series B Financing
BUSINESSWIRE
04 Dec 2023
Share Share
Seismic shakes up $121M for preclinical immunology programs

Seismic shakes up $121M for preclinical immunology programs
Gabrielle Masson FIERCE BIOTECH
04 Dec 2023
Share Share
Seismic Announces Presentation of Data for Advancing Biologics Drug Programs

Seismic Announces Presentation of Data for Advancing Biologics Drug Programs
BUSINESSWIRE
14 Jun 2023
Share Share
Seismic Announces Presentation of Data Showing Advances in Biologics Discovery

Seismic Announces Presentation of Data Showing Advances in Biologics Discovery
BUSINESSWIRE
11 May 2023
Share Share
Seismic Announces Preclinical Data for Immunoglobin Sculpting Enzyme

Seismic Announces Preclinical Data for Immunoglobin Sculpting Enzyme
BUSINESSWIRE
09 May 2023
Share Share
Seismic Therapeutic Appoints Melanie Manning as Chief People Officer

Seismic Therapeutic Appoints Melanie Manning as Chief People Officer
BUSINESSWIRE
27 Mar 2023
Share Share
Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer

Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer
BUSINESSWIRE
03 May 2022
Share Share
Seismic Appoints Eric Larson as Senior VP, Finance and Heather Vital as VP, R&D

Seismic Appoints Eric Larson as Senior VP, Finance and Heather Vital as VP, R&D
BUSINESSWIRE
13 Apr 2022
Share Share